Despite these many significant concerns, our Republican colleagues would have taxpayers pay monopoly prices for questionable drugs and devic...
The real angel investors in research and development for new cures in America are none other than American taxpayers.
over 200 device qualified in the first 3 years of the program. And some of those didn't actually show any useful benefits for patients and h...
I hope that moving forward we will not once again yield to the power of Big Pharma, instead, move to advance reasonable solutions that promo...
So, the patent system is set up to develop or encourage the development of novel products.
Civil servants need to be showing up for work.
Virtual presence is actually absence.
taxpayers in Texas, which is where I am from, and across the United States could be left footing the bill for these banks' mistakes and mism...
Americans are struggling under the weight of crippling inflation and families are being forced to decide whether to put food on the table or...
The Federal Reserve's report reviewed the supervision of Silicon Valley Bank. Key findings determined that Silicon Valley Bank's board of di...
The Biden Administration's massive spending spree of Executive Orders has fueled this crisis.
When I was diagnosed, it would have given me so much hope to have the opportunity to access treatments that can give me more time.
I tend to deal with the sensitive issues.
While my focus has been principally on drug pricing today, this hearing also, of course, deals with the question of medical devices.
We should be increasing our investment in medical research, not slashing it.
Finally, Mr. Chairman, we have a responsibility to ensure that patients come first and that it is their health and their livelihoods, not dr...
Rep. Troy Nehls (R-TX) recently introduced H.J.Res. 53, which mirrors Sen. Fischer's efforts by nullifying EPA's final rule.
The first step to leading to some type of resolution here is to know exactly why and how this happened.
